benzocaine 0.14 MG/MG / butamben 0.02 MG/MG / tetracaine 0.02 MG/MG Topical Gel
RxNorm concept 308645, clinical drug (scd). Prescribable name: benzocaine 14 % / butamben 2 % / tetracaine 2 % Topical Gel.
- RxCUI
- 308645
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/308645 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
benzocaine 14 % / butamben 2 % / tetracaine 2 % Topical Gel
Related concepts
- tetracaine 0.02 MG/MG (SCDC, consists of)
- benzocaine 0.14 MG/MG (SCDC, consists of)
- butamben 0.02 MG/MG (SCDC, consists of)
- Topical Gel (DF, has dose form)
- benzocaine 0.14 MG/MG / butamben 0.02 MG/MG / tetracaine 0.02 MG/MG Topical Gel [Cetacaine] (SBD, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 308645 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/308645 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 308645. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.